Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,578Revenue (TTM) $M1,595Net Margin (%)44.4Altman Z-Score11.7
Enterprise Value $M4,525EPS (TTM) $14.9Operating Margin %65.4Piotroski F-Score7
P/E(ttm)8.9Beneish M-Score-1.7Pre-tax Margin (%)65.5Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %--Quick Ratio4.1Cash flow > EarningsN
Price/Sales3.95-y EBITDA Growth Rate %36.3Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow13.8y-y EBITDA Growth Rate %4.1ROA % (ttm)32.2Higher Current Ratio y-yY
Dividend Yield %--PEG0.2ROE % (ttm)42.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M42.4ROIC % (ttm)97.4Gross Margin Increase y-yN

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
UTHRJoel Greenblatt 2016-09-30 Reduce-0.06%$107.73 - $129.64
($120.15)
$ 131.519%Reduce -13.54%317,358
UTHRKen Fisher 2016-09-30 Add$107.73 - $129.64
($120.15)
$ 131.519%Add 1.03%3,124
UTHRDavid Dreman 2016-06-30 Add0.17%$98.33 - $121.03
($111.54)
$ 131.5118%Add 2036.00%2,670
UTHRJoel Greenblatt 2016-06-30 Add0.01%$98.33 - $121.03
($111.54)
$ 131.5118%Add 1.24%367,075
UTHRJoel Greenblatt 2016-03-31 Add0.04%$108.47 - $156.61
($127.11)
$ 131.513%Add 10.43%362,565
UTHRGeorge Soros 2016-03-31 Sold Out -0.01%$108.47 - $156.61
($127.11)
$ 131.513%Sold Out0
UTHRKen Fisher 2016-03-31 Reduce$108.47 - $156.61
($127.11)
$ 131.513%Reduce -1.43%3,092
UTHRDavid Dreman 2016-03-31 Buy $108.47 - $156.61
($127.11)
$ 131.513%New holding125
UTHRFirst Eagle Investment 2015-12-31 Sold Out -0.18%$119.57 - $160.91
($146.21)
$ 131.51-10%Sold Out0
UTHRJoel Greenblatt 2015-12-31 Add0.05%$119.57 - $160.91
($146.21)
$ 131.51-10%Add 9.00%328,310
UTHRGeorge Soros 2015-12-31 Buy 0.01%$119.57 - $160.91
($146.21)
$ 131.51-10%New holding4,400
UTHRKen Fisher 2015-12-31 Add$119.57 - $160.91
($145.83)
$ 131.51-10%Add 7.51%3,137
UTHRJoel Greenblatt 2015-09-30 Add0.05%$131.24 - $179.15
($160.64)
$ 131.51-18%Add 15.35%301,205
UTHRFirst Eagle Investment 2015-09-30 Add0.04%$131.24 - $179.15
($160.64)
$ 131.51-18%Add 28.56%548,807
UTHRKen Fisher 2015-09-30 Add$131.24 - $179.15
($160.64)
$ 131.51-18%Add 19.10%2,918
UTHRJoel Greenblatt 2015-06-30 Reduce-0.04%$159.69 - $188.56
($179.77)
$ 131.51-27%Reduce -10.29%261,125
UTHRFirst Eagle Investment 2015-06-30 Add0.02%$159.69 - $188.56
($179.77)
$ 131.51-27%Add 14.57%426,880
UTHRJoel Greenblatt 2015-03-31 Reduce-0.03%$124.93 - $179.51
($152.45)
$ 131.51-14%Reduce -9.91%291,077
UTHRKen Fisher 2015-03-31 Buy $124.93 - $179.51
($152.45)
$ 131.51-14%New holding2,450
UTHRFirst Eagle Investment 2015-03-31 Add$124.93 - $179.51
($152.45)
$ 131.51-14%Add 3.44%372,580
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

UTHR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


UTHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROTHBLATT MARTINE AChairman & CEO 2016-12-01Sell1,246$126.867.78view
ROTHBLATT MARTINE AChairman & CEO 2016-11-25Sell1,233$132.812.95view
ROTHBLATT MARTINE AChairman & CEO 2016-11-17Sell1,232$132.942.85view
PATUSKY CHRISTOPHERDirector 2016-11-10Sell5,000$131.424.04view
PATUSKY CHRISTOPHERDirector 2016-11-10Sell5,000$131.424.04view
PATUSKY CHRISTOPHERDirector 2016-11-10Sell5,000$131.424.04view
PATUSKY CHRISTOPHERDirector 2016-11-10Sell5,000$131.424.04view
ROTHBLATT MARTINE AChairman & CEO 2016-11-10Sell1,240$129.825.32view
ROTHBLATT MARTINE AChairman & CEO 2016-11-03Sell1,272$116.9416.92view
ROTHBLATT MARTINE AChairman & CEO 2016-10-27Sell1,272$117.0616.8view

Quarterly/Annual Reports about UTHR:

News about UTHR:

Articles On GuruFocus.com
Gurus Invest in Undervalued Biotech Stocks Nov 25 2016 
6 Undervalued Stocks Trading Below the Peter Lynch Value Oct 26 2016 
These Five Stocks Show a Combination of Value and Growth Aug 03 2016 
Worst Performance YTD: MasterCard, Lazard Aug 03 2016 
5 Mid-Cap Stocks With Low Enterprise Multiples Aug 03 2016 
10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate? Jul 01 2016 
Gurus Invest in Top Biotechnology Stocks Jun 20 2016 
United Therapeutics Is a Value Investor's Biotech Dream Apr 28 2016 
Cummins and Deckers are Candidates for a January Bounce Nov 20 2015 
Estimated Revenue Up 5% Stock Screen Nov 18 2015 

More From Other Websites
Hedge Funds Are Selling Patterson Companies, Inc. (PDCO) Dec 02 2016
Pig organs to save lives by end of decade: United Therape... Dec 01 2016
Hedge Funds Are Buying WellCare Health Plans, Inc. (WCG) Dec 01 2016
United Therapeutics Corp. breached its 50 day moving average in a Bullish Manner : UTHR-US :... Nov 09 2016
Palo Alto Investors’s Bets on ABIOMED, Inc. (ABMD), United Therapeutics Corporation (UTHR) and... Nov 08 2016
Mallinckrodt PLC (MNK) & Depomed Inc (DEPO) Helped Consonance Capital to Massive Q3 Returns Nov 04 2016
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating United Therapeutics Corporation... Nov 01 2016
UNITED THERAPEUTICS CORP Financials Nov 01 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of... Oct 31 2016
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating United Therapeutics Corporation... Oct 31 2016
United Therapeutics Corp. :UTHR-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016 Oct 31 2016
United Therapeutics (UTHR) Beats Q3 Earnings, Sales Miss Oct 28 2016
United Therapeutics upgraded by Ladenburg Thalmann Oct 28 2016
Edited Transcript of UTHR earnings conference call or presentation 27-Oct-16 1:00pm GMT Oct 27 2016
United Therapeutics upping the ante on R&D spending Oct 27 2016
United Therapeutics Corp Earnings Call scheduled for 9:00 am ET today Oct 27 2016
Q3 2016 United Therapeutics Corp Earnings Release - Before Market Open Oct 27 2016
United Therapeutics beats 3Q profit forecasts Oct 27 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)